drugset / Trial / NCT00726336

GSK1349572 Drug Interaction With Tenofovir

NCT00726336

Phase 1 Completed 16 enrolled GlaxoSmithKline
Non-randomizedTreatment

Summary

A study in healthy volunteers to determine whether there is a drug interaction between GSK1349572 and tenofovir

Timeline

Start
2008-08
Primary completion
2008-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Dolutegravir Other / unclassified
Subject Tenofovir Small molecule

Indications

No indication recorded.